Form 4: Organogenesis Holdings Inc. CEO Gary S. Gillheeney Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Gary S. Gillheeney, President and CEO of Organogenesis Holdings Inc., reports the disposition of Class A Common Stock to cover tax obligations.
Summary
- On February 15 and 16, 2025, Gary S. Gillheeney, the President and CEO of Organogenesis Holdings Inc., reported the disposition of Class A Common Stock.
- The transactions were related to the satisfaction of tax obligations.
- The sales occurred at a price of $3.7 per share.
- Following these transactions, Gillheeney directly owns 2,807,108 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity by the CEO of Organogenesis Holdings Inc.
Stakeholder Impact
- The disposition of shares by the CEO could have a minor impact on shareholder sentiment, but the reason for the sale (tax obligations) is generally viewed as routine.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of transaction involving Class A Common Stock disposition. |
| 02/16/2025 | Date of transaction involving Class A Common Stock disposition. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Organogenesis Holdings Inc., Gary S. Gillheeney, Form 4, Beneficial Ownership, Class A Common Stock, Disposition, Tax Obligations, ORGO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.